• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 3
  3. Authors

Online ISSN: 2515-8260

Volume8, Issue3

Thalidomide is better than Rapamycin in prevention of neovascularization after laser photocoagulation in dorsal window chamber rat model

    Kareem Esam Maha Fadel Lilian Naoum Mahmoud S. Elbasiouny

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 3, Pages 863-878

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Objectives: -This study examines the effect of two different antiangiogenic drugs (rapamycin
and thalidomide) in prevention of neovascularization when locally used, after laser
coagulation through dorsal skinfold window chamber rat model.
- Determine what is the most effective antiangiogenic drug when used locally and its
potential side effects.
Methodology:
The study includes 3 groups, each group contains 10 rats Thalidomide, Rapamycin and
control group (laser group). Blood vessels in the dorsal window chambers implanted on
dorsal skin of albino rats were irradiated by Diode laser pulses until coagulation occurs.
Blood flow and vessels structure were documented with high definition camera to evaluate
photocoagulation and reperfusion. Treatment groups received the treatment drug which
was injected to the widow’s medial side, every 3 days’ intervals for 2 weeks after laser
irradiation.
Keywords:
    Angiogenesis-Antiangiogenic Drugs-Diode laser-Sirolimus-Thalidomide-Skinfold window chamber
  • PDF (462 K)
  • XML
(2021). Thalidomide is better than Rapamycin in prevention of neovascularization after laser photocoagulation in dorsal window chamber rat model. European Journal of Molecular & Clinical Medicine, 8(3), 863-878.
Kareem Esam; Maha Fadel; Lilian Naoum; Mahmoud S. Elbasiouny. "Thalidomide is better than Rapamycin in prevention of neovascularization after laser photocoagulation in dorsal window chamber rat model". European Journal of Molecular & Clinical Medicine, 8, 3, 2021, 863-878.
(2021). 'Thalidomide is better than Rapamycin in prevention of neovascularization after laser photocoagulation in dorsal window chamber rat model', European Journal of Molecular & Clinical Medicine, 8(3), pp. 863-878.
Thalidomide is better than Rapamycin in prevention of neovascularization after laser photocoagulation in dorsal window chamber rat model. European Journal of Molecular & Clinical Medicine, 2021; 8(3): 863-878.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 206
  • PDF Download: 310
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus